All financings
COMPANY TRANSACTIONS

OS Therapies Inc.

OSTXNYSE AmericanBiotechnology

Deal details

1 transaction in the database

TRANSACTION REPORT · SEC DISCLOSURES

Deal notes

ContextDeal context

This is an ATM facility event. The capacity shown is not cash raised.

Gross proceedsNo cash proceeds
Offering price—
Discount to prior close—
Warrant coverage—
Sales agentJefferies LLC

Transaction overview

01

OS Therapies Inc disclosed an at-the-market program event: facility established. Authorized capacity is $75.0M. This event does not record cash proceeds raised.

Financing type
ATM
Announcement date
—
SEC disclosure date
Aug 21, 2026
Agreement date
Aug 21, 2026
Pricing date
—
Closing date
—
Filing date
Aug 21, 2026
Status
Announced
Market cap before SEC disclosure
$69.4M
Prior closing price
$1.58
Raise as % of market cap
—

Market data · FMP

Historical market cap
$69,368,571
Market date
Aug 20, 2026
Closing price
$1.58
Latest reported shares outstanding
45,538,100
Latest reported float shares
25,970,036
Share-data date
Oct 2, 2026

Market cap and closing price are from FMP for the date shown. Shares are FMP’s latest available snapshot, dated separately. Updated Oct 2, 2026.

Financial Modeling Prep ↗

Financing terms

02

At-the-market program

Capital event
Facility established
Authorized capacity
$75.0M
Proceeds raised
Not reported as raised
Shares sold
—
Average sale price
—
Relevant period
Not applicable
Sales commission
3%

Fees & transaction economics

03
Placement agent / underwriting fee
3%
Agent fee amount
—
Management fee
—
Other offering expenses (estimated)
—
Net proceeds (estimated)
—
Net proceeds as % of gross
—

Fee amounts reflect disclosed inputs. Unknown expense components are not assumed to be zero.

3% sales commission; counsel reimbursement capped at $100,000 at execution plus specified ongoing disbursements. Total offering expenses estimated at $350,000 excluding commissions and Jefferies expense reimbursement; actual costs and proceeds are unknown.

Transaction participants

04
Investor names: —

Source documents

05

SEC filings, exhibits and attributed market data. The report separates disclosed facts, calculated metrics, and unknown terms.

424B5 · OS Therapies IncSEC filing · Aug 21, 2026
Open source ↗
8-K · OS Therapies IncSEC filing · Aug 21, 2026
Open source ↗
EX-1.1 · OS Therapies IncSEC filing · Aug 21, 2026
Open source ↗
EX-5.1 · OS Therapies IncSEC filing · Aug 21, 2026
Open source ↗
FMP historical market data · OSTXMarket data · Aug 20, 2026
Open source ↗
SEC deal terms · FMP market data where available · Initial research sample, not complete market coverage. AI-assisted source review; original evidence is available in each report. Names and tickers reflect the transaction date. A dash (—) means the value is unavailable.